Table 4 |
||||
|
APACHE II and SOFA scores, cytokine levels, gastric intramucosal pH and gastric intramucosal carbon dioxide tension |
||||
|
Variable |
Baseline |
Immediately after NAC infusion |
24 hours after NAC infusion |
48 hours after NAC infusion |
|
|
||||
|
APACHE II score |
||||
|
NAC |
13.14 ± 3.79 |
- |
13.33 ± 3.83 |
12.74 ± 3.87 |
|
Control |
15 ± 3.58 |
- |
15.34 ± 3.30 |
15.69 ± 3.4 |
|
SOFA score |
||||
|
NAC |
5.62 ± 2.52 |
5.55 ± 2.04 |
5.48 ± 2.57 |
5.48 ± 2.7 |
|
Control |
6.53 ± 2.2 |
6.92 ± 2.59 |
7.15 ± 2.9 |
7.15 ± 2.86 |
|
Tumour necrosis factor-α (pg/ml) |
||||
|
NAC |
25.58 ± 15.8 |
26.02 ± 16.1 |
22.68 ± 13.9 |
28.17 ± 26.8 |
|
Control |
22.57 ± 28.2 |
24.90 ± 13.56 |
25.05 ± 21.8 |
28.25 ± 24.3 |
|
IL-1β (pg/ml) |
||||
|
NAC |
6.68 ± 1.85 |
6.38 ± 1.07 |
5.91 ± 1.26 |
5.57 ± 1.62 |
|
Control |
5.35 ± 1.32 |
5.09 ± 0.30 |
5.34 ± 1.01 |
5.11 ± 0.58 |
|
IL-2 receptor (U/ml) |
||||
|
NAC |
1847 ± 1366 |
1918 ± 1450 |
1829 ± 1427 |
1816 ± 1806 |
|
Control |
2288 ± 1503 |
2372 ± 1531 |
2382 ± 1599 |
2168 ± 843 |
|
IL-6 (pg/ml) |
||||
|
NAC |
100.26 ± 88 |
100.22 ± 19.8 |
110.51 ± 37 |
100.38 ± 38 |
|
Control |
115.85 ± 85 |
115.64 ± 19.8 |
113.86 ± 27 |
119.48 ± 38 |
|
IL-8 (pg/ml) |
||||
|
NAC |
161.50 ± 55 |
161.6 ± 10.3 |
162.1 ± 12.4 |
168.8 ± 113 |
|
Control |
172.95 ± 27 |
163.3 ± 28.4 |
169.6 ± 28.6 |
171.0 ± 31 |
|
Gastric intramucosal pH |
||||
|
NAC |
8.41 ± 0.21 |
8.43 ± 0.22 |
8.43 ± 0.17 |
- |
|
Control |
8.26 ± 0.18 |
8.31 ± 0.16 |
7.45 ± 0.47 |
- |
|
Gastric intramucosal carbon dioxide tension (mmHg) |
||||
|
NAC |
67.2 ± 20.1 |
70.2 ± 15.6 |
69.0 ± 21.9 |
- |
|
Control |
68.7 ± 22.8 |
69.7 ± 23 |
68.9 ± 25.7 |
- |
|
|
||||
|
Data are expressed as means ± standard deviation. APACHE, Acute Physiology and Chronic Health Evaluation; IL, interleukin; NAC, N-acetyl-L-cysteine; SOFA, Sepsis-related Organ Failure Assessment. |
||||
|
Emet et al. Critical Care 2004 8:R172 doi:10.1186/cc2866 |
||||